Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY and GLENN LARKIN

Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark

When building your watch list, look for stocks with an 80 or higher RS Rating. Amicus Therapeutics just cleared that benchmark with an upgrade from 77 to 82.

When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

This proprietary rating identifies market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of other stocks on the major indexes.

History shows that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves.

Looking For The Best Stocks To Buy And Watch? Start Here

Amicus Therapeutics is trying to complete a consolidation with a 14.10 buy point. This is after failing to hold gains from a previous cup with handle pattern. See if the stock can continue moving higher and then clear the breakout price in volume at least 40% above average.

The company reported 0% earnings growth in its most recent report. Sales gains came in at 17%.

Amicus Therapeutics earns the No. 39 rank among its peers in the Medical-Biomed/Biotech industry group. HUTCHMED (China) ADR and Kiniksa Pharmaceuticals are also among the group's highest-rated stocks.

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.